x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Dr RR Baliga"s "Got Knowledge Doc" Podkast

Dr RR Baliga, MD, MBA

"Got Knowledge Doc" Podkast with Dr. RR Baliga The "Got Knowledge Doc" Podkast, hosted by Dr. Ragavendra R. Baliga, is a knowledge-driven platform designed for physicians and healthcare providers seeking to stay at the forefront of medical science and innovation. With a distinguished career in cardiovascular medicine and academic leadership, Dr. Baliga engages with leading experts to explore cutting-edge research, emerging technologies, and transformative insights in medicine and beyond. Each

science natural sciences

All Episodes

04:44

💊📉 Mix, Match, and Lower: Predicting BP Drops with...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/29

🚨 New in The Lancet (2025) 🚨 A mega meta-analysis of 484 RCTs (104K+ participants) offers a game-changing approach to hypertension management! 💊📉 Instead of guessing how much BP will drop, now you can predict it—by drug, dose, and combo! 🎯 Like statins for LDL, this study introduces low-, moderate-, and high-intensity BP regimens based on expected mmHg reductions. 💡 Use the free calculator 🔢 at www.bpmodel.org and rethink the “measure-treat-measure” loop. 🩺 Data-driven. Predictable

en

04:43

Partial Hearts. Whole Hope. Lasting Change. 🧩❤️🔬 A...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/28

🧒❤️ Partial Heart Transplant: A Growing Solution for Growing Hearts! 🌱🔬 🚨 Pediatric patients with congenital heart valve disease often face multiple surgeries due to non-living valve grafts that don’t grow. This landmark study from @DukeHealth shows how living valves via partial heart transplant can change the game. 📊 In 19 patients (median age: 97 days), transplanted valves showed true annular and leaflet growth — with low immunosuppression and no valve-related reinterventions. The

en

05:10

🧬🔬 From Barnyard to Human Chest: 216 Hours of Pig...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/28

🐖🫁 World First: Pig Lung Transplanted into Human 🧬🌍 In a groundbreaking step for xenotransplantation, a team in China successfully transplanted a genetically modified pig lung into a brain-dead human recipient. The lung functioned for 216 hours without hyperacute rejection, offering hope to thousands on organ waitlists. 🔬 Key breakthroughs: • 6-gene-edited donor pig • No Porcine Endogenous Retrovirus (PERV-C) detected 🦠 • Controlled immune response 🛡️ • PGD observed but stabilized 💉 📖

en

04:38

🧬 One Size Doesn’t Fit All: Tailoring NT-proBNP by Age

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/27

🧬 Pre-Heart Failure? Let Age Speak! 👵👴 New study in JACC compares fixed vs age-adjusted NT-proBNP cutoffs for defining pre–heart failure (Pre-HF) in over 22,000 adults across ARIC, MESA, and CHS cohorts. 📉 Key Insight: Age-adjusted cutoffs reduce overdiagnosis in older adults 🧓 and improve risk prediction for heart failure hospitalization 🏥. 📊 With better C-statistics, NRI, IDI, and a lower number needed to screen, the age-specific approach proves more precise—especially in those ≥75

en

05:26

🧬🛡️🔬 Nivolumab Before Surgery: A Lifesaving Combo in...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/27

🚨 Game-Changer in Lung Cancer! 🫁💉 The 5-year results from CheckMate 816 are in! Neoadjuvant nivolumab + chemotherapy significantly improved survival in resectable NSCLC 🎯 ✅ 65.4% 5-year OS vs. 55.0% with chemo alone 🧬 pCR = 95.3% survival 📉 ctDNA clearance = better outcomes ⚖️ Time to rethink neoadjuvant strategies 📚 Read in NEJM: A landmark in thoracic oncology! #LungCancer #Immunotherapy #NSCLC #Nivolumab #Oncology #CancerResearch #PrecisionMedicine

en

05:34

🔥 Beyond LDL: 🔬 Residual Risk After PCI: It’s the...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/27

🚨 New insights from EHJ 2025! 🚨 In statin-treated patients undergoing PCI, inflammation (hsCRP ≥2 mg/L)—not elevated LDL-C—was the strongest predictor of MACE at 1 year 🔥🧪 📊 Bay et al. show that residual inflammatory risk carries a 1.8x higher hazard for adverse events, while LDL-C alone showed no independent risk 💥 🧠 Time to shift focus beyond lipids: consider anti-inflammatory therapies, remnant cholesterol, and Lp(a) in risk stratification 🩺🎯 📖 Read the study ➡️

en

03:37

Dr RR Baliga's Philosophical Discourses: Averroes...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/26

🔎 Averroes (Ibn Rushd, 1126–1198), the “Father of Rationalism,” bridged Islam & the West through philosophy, medicine & law. 🌍 His commentaries on Aristotle, theory of the intellect, and medical insights (stroke, Parkinson’s, retina) shaped centuries of thought. 📚 His legacy reminds us that reason, faith & science can coexist in pursuit of truth. 💡 #Philosophy #Medicine #History

en

06:09

Calcium-Free ≠ Risk-Free ❌💔: 🫀🔍 LDL-C’s Silent Strike...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/25

🚨 New Study Alert 🧬🫀 Think a CAC score of zero means you’re in the clear? Think again. A massive cohort from the Western Denmark Heart Registry (n = 23,777) shows that elevated LDL-C is strongly associated with non-calcified plaque 🧱 and future coronary events 💥—even in those with CAC = 0. 📈 Each 1 mmol/L (~39 mg/dL) rise in LDL-C increases the odds of plaque (aOR 1.21) and risk of CHD (aHR 1.28). 🔥 Risks were highest in individuals ≤45 years—a silent threat during prime decades of life

en

06:39

Stuck Surfactant, Freed by Science 🔬🧼➡️🫁

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/25

🚨 New in NEJM 🫁: The IMPALA-2 trial shows that inhaled molgramostim significantly improves gas exchange, quality of life, and exercise capacity in patients with autoimmune pulmonary alveolar proteinosis (aPAP)—a rare disease driven by GM-CSF autoantibodies. 💨 Say goodbye to whole-lung lavage—this is a bench-to-bedside success story 30 years in the making. 🔬 From GM-CSF knockout mice ➡️ inhaled cytokine therapy ➡️ regulatory-grade RCT. 🏆 A major win for translational respiratory medicine.

en

04:37

Beyond the Golden Hour ⏳🧬🧠: Late Lysis, Salvageable...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/24

🚨 New Stroke Trial Alert! 🧠💉 Can IV alteplase help beyond the 4.5-hour mark? The HOPE trial (JAMA 2025) says YES—if perfusion imaging shows salvageable brain tissue 🧬🕑. 📊 Functional independence at 90 days improved from 26% ➡️ 40%, despite a small uptick in symptomatic ICH (3.8%). 🌍 Game-changer for patients in low-resource settings where thrombectomy isn’t an option. 📖 Read more: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.12063 #StrokeCare #Thrombolysis

en

06:06

Beyond Sugar & Fat 🔬💊⚖️ The GLP-1 Revolution in...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/24

🚀 Exciting breakthroughs in metabolic medicine! 💊 This August 2025 Nature Reviews Drug Discovery review by Dr. Daniel Drucker dives deep into the evolution of GLP-1-based therapies—covering semaglutide, tirzepatide, multi-agonists, oral small molecules, and their growing impact beyond diabetes into obesity, liver disease, and neurodegeneration. 🧠⚖️💥 📉 From gut hormones to global health, GLP-1 therapies are redefining chronic disease care. 🔗 Read, reflect, and get ready for what’s next: #GLP1

en

05:31

Fat Maps, Heart Clocks, and Gender Gaps 🗺️❤️♀️

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/23

🚨 New insights from the European Heart Journal! 🫀✨ This study shows that where you store fat — not just how much — matters for how your heart and arteries age. 📌 Android fat (belly) = faster cardiovascular aging 📌 Gynoid fat (hips/thighs) = protective, especially in women 🧬 Using MRI (ShMOLLI), metabolomics & AI (CatBoost), researchers predicted cardiovascular age from fat patterns. 💡 A wake-up call for personalized risk, not just BMI! #CardioMetabolic #PrecisionMedicine #VascularAging

en

06:10

🔬 Detect, Define, Deliver: A Prostatitis Primer for...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/23

👨‍⚕️🔬 Just explored the latest JAMA review on Prostatitis—a masterclass in clarity and clinical relevance! From LUTS to CP/CPPS, it unpacks the full spectrum: 🧪 Meares-Stamey testing, 📊 NIH-CPSI scoring, and 🚀 modern management strategies. A must-read for anyone navigating the nuanced world of male pelvic health. #Urology #MensHealth #Prostatitis #PrecisionMedicine 🧠📘

en

06:14

Heart Failure Trials ⚖️ Therapies 💊 FDA Decisions 📜

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/22

🚨 New in JACC (Aug 2025): Evidentiary Landscape of HF Therapies 🫀 Over the last decade, the heart failure field has shifted from the “mortality reduction era” (ACEIs, β-blockers, MRAs) ➡️ to the “hospitalization reduction era” (SGLT2i, ARNI in HFpEF, iron therapy). 🔑 Key Insights: ⚖️ FDA decisions reflect both rigor and flexibility — approving sacubitril/valsartan in HFpEF despite a missed primary endpoint, while rejecting omecamtiv mecarbil despite statistical significance. 🧬 Enrichment

en

04:03

🧬 Mesenchymal Drift, Aging Cells, Rejuvenation...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/22

🧬 Mesenchymal Drift: A New Hallmark of Aging & Disease 🧬 Researchers uncover that Mesenchymal Drift (MD)—the widespread activation of mesenchymal genes across tissues—is a conserved feature of aging and multiple diseases. 📉 High MD = worse outcomes (e.g., in Idiopathic Pulmonary Fibrosis, survival dropped from 1,027 to 294 days). 🔄 Excitingly, partial reprogramming with Yamanaka factors (OSKM) reverses MD before cells lose their identity, restoring youthful transcriptional programs. ✨ This

en

05:44

Zap 💥, Shield 🛡️, Survive 💓: Ablation Wins for AF

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/21

🚨 New insights on atrial fibrillation (AF) treatment! A major meta-analysis in Annals of Internal Medicine 🧠📊 confirms that catheter ablation reduces stroke 🧨, heart failure hospitalizations 🏥, and mortality ⚰️—especially in patients with HF. While surgical ablation with LAA occlusion shows benefit in stroke prevention, catheter-based strategies 💉🔥 continue to lead in outcomes and safety. 💡 Time to rewire rhythm control strategies. #AtrialFibrillation #Cardiology #StrokePrevention

en

04:09

🥃 Small Sip, Big Risk: Rethinking Alcohol & Health

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/21

🚨 New insights from Annals of Internal Medicine challenge long-held beliefs about alcohol 🍷 and health 🧬. A 2025 U.S. Surgeon General advisory links even modest drinking to increased cancer risk 🎗️—especially breast and oral cancers. Experts now urge clearer labeling, better patient counseling 🩺, and culturally normalizing abstinence 🌱. Is it time to rethink the “glass of red wine” advice? 🧐 #PublicHealth #AlcoholAwareness #PreventiveMedicine #AnnalsOfIM

en

06:44

Renal Nerves 🔥 Blood Pressure 💉 Device Therapy 🚀

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/20

💡 Renal Denervation: A New Era in Hypertension Care 🩺 Despite decades of effective medications, only ~25% of patients worldwide achieve blood pressure control. Non-adherence remains a huge barrier. 📉 This Nature Reviews Cardiology article (Fisher & Kirtane, Sept 2025) explores the journey of renal denervation (RDN) — from Smithwick’s sympathectomy in the 1950s to today’s FDA-approved radiofrequency 🔥 and ultrasound 🔊 catheter systems. ✅ Sham-controlled trials show RDN lowers BP by 5–10

en

06:02

Diverticulitis 📊🔬💊: Patterns, Pitfalls, and Practice

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/20

📘 New Insights on Diverticulitis 📊🔬💊 Did you know that while 1–4% of people with diverticulosis develop diverticulitis, it still accounts for ~200,000 hospitalizations annually in the US and >$6.3B in healthcare costs? 🚑💰 ✅ CT scan remains the gold standard for diagnosis 🖼️ ✅ Observation & pain control are first-line for uncomplicated cases 💊 ✅ Antibiotics reserved for high-risk groups (elderly, immunocompromised, pregnant, systemic illness) ⚠️ ✅ Surgery indicated for recurrent or

en

06:24

Hypertension: Old Foe 🥊, Novel Therapies 🛡️, Brighter...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2025/08/19

🚨 Hypertension remains the world’s #1 killer — yet fewer than 1 in 4 patients achieve control. 💊 Exciting innovations are reshaping the field: ✔️ Aprocitentan (endothelin receptor antagonist) – first new class in decades ✔️ siRNA (zilebesiran) – 6-monthly dosing, tackling adherence ✔️ Aldosterone synthase inhibitors – overcoming “aldosterone escape” ✔️ Non-steroidal MRAs & neprilysin inhibitors – precision targeting with broader benefits ✔️ Single-pill & quadpill combos – simplifying therapy,

en

919 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter